Desktop Site
|
25 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,339.44
+486.50
+0.66 %
Corporate Announcement
Security Code
532296
Company
GLENMARK PHARMACEUTICALS LTD.
Exchange Received Time
16/05/2017 08:50:30
Exchange Disseminated Time
16/05/2017 08:50:34
Time Taken
00:00:04
Press Release |
5/16/2017 8:50:31 AM
Sub:- Glenmark Pharmaceuticals to Initiate Clinical Study for GBR 1342, Second Investigational New Drug from Immuno-Oncology Portfolio With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.
Attachment
<< Back
Recently Viewed